This lecture explores the evolution of contact lenses from their historical origins to current prescribing trends and future disruptive innovations in clinical practice. Contact lenses are worn by approximately 150 million people worldwide, representing around 2% of the global population and approximately 4% of those requiring vision correction . Over the past three decades, major advances have transformed prescribing patterns, with significant growth in daily disposable lenses, silicone hydrogel materials, soft toric lenses, multifocal lenses for presbyopia, and more recently, myopia control designs.The session examines the drivers behind these changes and questions whether daily disposables have become the default lens choice in all cases. Consideration is given to cost, environmental sustainability, parameter availability, and long-term wearer suitability. Evidence relating to silicone hydrogel adoption, unmet toric prescribing needs, and the large untapped presbyopic market is discussed, alongside the importance of addressing wearer discontinuation caused by discomfort, poor handling, and convenience factors. Emerging concepts such as parainflammation and advances in lens surface technology, packaging, and handling design are reviewed as opportunities to improve long-term success.The lecture also considers future step changes that may fundamentally alter the role of contact lenses in eye care. These include diagnostic lenses capable of monitoring glucose, glaucoma, dry eye disease, and systemic disease biomarkers; therapeutic lenses for ocular drug delivery; and the development of digital contact lenses incorporating biosensors and smart technologies. Together, these innovations suggest that contact lenses may evolve from simple vision correction devices into sophisticated platforms for diagnosis, treatment, and continuous ocular health monitoring.